Catalyst Compounds IGF-1 LR3

Description

IGF-1 LR3 is a recombinant, structurally modified variant of insulin-like growth factor 1 with reduced affinity for binding proteins and an extended activity window. It functions as an IGF-1 receptor agonist in laboratory study.

Research has examined receptor signaling cascades, cell proliferation and differentiation, protein-synthesis pathways, and metabolic markers in cultured cells and animal models. Its prolonged activity makes it a practical tool for growth-factor pathway analysis.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.